Anika Therapeutics, Inc.: accounts_payable

Value{"amount": 1201226, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Period (as of 2014-12-31)
Statussuperseded
EntityAnika Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001171843-15-001395
Retrieved: 2026-08-19T09:02:47.738007+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000898437/accounts-payable/2014-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6079b1e2-0530-4dc6-92cc-46c70f771f5f

History